Live Case Demonstration #4

Friday, April 20
9:00 AM - 10:00 AM
Location: Lullwater Ballroom

Ian J. Sarembock, MB, ChB, MD

Medical Director, Valve & Structural Heart Care Line
The Christ Hospital Health Network

Ian J. Sarembock, MB, CHB, MD, FACC
Ohio Heart & Vascular Center
Medical Director, Valve & Structural Heart Care Line
Harold C Schott Foundation Endowed Chair in Structural Heart
The Christ Hospital Health Network

Dr. Sarembock, an interventional cardiologist received his medical degree and doctorate at the University of Cape Town. He spent two years at Yale University, then moved on to the University of Virginia, where he did translational and clinical research, taught and practiced medicine. He was Director of the Coronary Care Unit and the Harrison Distinguished Teaching Professor of Internal Medicine. He helped create and maintain translational and clinical research programs and was a leading participant nationally in NIH and industry-supported clinical trials. In 2007, he joined the Ohio Heart and Vascular Center. He has authored a wide range of publications in in high-impact journals and contributed more than 250 peer-reviewed articles, abstracts, book chapters, and invited publications in cardiology. In addition, he is a peer reviewer for many of the leading journals in both clinical and investigational cardiovascular medicine.


Send Email for Ian Sarembock

S. Hinan Ahmed, MD, FACC, FSCAI

Associate Professor
UT Health, San Antonio
UT Health

Dr. S. Hinan Ahmed, MD, FACC, FSCAI is Associate Professor of Cardiology and Cardiothoracic Surgery at UTHSCSA. Dr. Ahmed is the Associate Program Director for the Interventional Cardiology fellowship and Director of the Cardiac Catheterization laboratories at UTHSC and VA Medical Center, San Antonio. In addition to his clinical duties Dr. Ahmed is involved in multiple research studies and teaching responsibilities at UTHSC. He is the Associate Editor for Catheterization andCardiovascular Interventions. His areas of interest in Interventional Cardiology include anti-platelet therapies, atherosclerotic and structural heart disease.


Send Email for S. Hinan Ahmed

Van T. Crisco, MD, FSCAI

Medical Director
Sarah Cannon CV Research Institute, Memorial Hospital Jacksonville

An Emory Interventional Cardiology alum from 2000, Dr. Crisco is a partner at First Coast Heart and Vascular Center in Jacksonville, Florida. He is an interventional cardiologist with over 18 years of experience in the field and has a high volume interventional practice including peripheral, coronary and structural heart disease management. He is the Medical Director of the Sarah Cannon Cardiovascular Research Institute at Memorial Hospital Jacksonville where he is actively involved in clinical trialing of cardiac devices, drug therapies, and patient management strategies. He holds patents on cardiac devices and drug management systems and has enjoyed success in the cardiac device industry.


Send Email for Van Crisco

Gene Parrino, MD

Chief, Section of Thoracic and Cardiovascular Surgery
Ochsner Clinic Foundation
University of Queensland

Dr. Gene Parrrino is the Chief of the Section of Thoracic and Cardiovascular Surgery at the Ochsner Clinic in New Orleans. He is a cardiac surgeon with over 14 years of experience. His main interestes are mitral valve surgery, aortic surgery, and cardiothoracic transplantation.


Send Email for Gene Parrino

Puvi N. Seshiah, MD,FRCP, FSCAI

Director, Cardiac Cath Lab
Trihealth Heart Institute- Good Samarital Hospital

Dr. Puvi Seshiah is the Director of Structural Heart Interventions and Cardiac Cath Lab Director at Trihealth Heart Institute in Cincinnati, Ohio. He completed his cardiovascular and interventional training at Emory University hospital. He is an interventional cardiologist with interest in Structural interventions. He is a principal investigator for newer valve device trials.


Send Email for Puvi Seshiah

Michael Ragosta, MD, FSCAI

Director, Cardiac Catheterization Laboratory
University of Virginia Health System
University of Virginia

Dr. Michael Ragosta is Professor of Medicine and Director of the Cardiac Catheterization Laboratory at the University of Virginia and an Interventional Cardiologist with over 20 years experience. His main clinical interests include clinical hemodynamics, valvular heart disease, transcatheter therapies for aortic stenosis and the percutaneous treatment of high risk and complex coronary artery disease subsets including left main stem intervention, chronic total occlusion and multivessel disease. His research interests are many and include coronary physiology, new percutaneous treatments for valvular and coronary disease and coronary intervention in high risk subsets.


Send Email for Michael Ragosta

John S. Douglas, Jr., MD, FSCAI

Professor of Medicine
Emory University School of Medicine
Emory University School of Medicine

Dr John Douglas is a Professor of Medicine in the Cardiology Division of the Emory University School of Medicine and Director of the Interventional Cardiology Fellowship Program at Emory University . He was a partner of the late Andreas Gruentzig and participated in many of the balloon angioplasty and stent trials that formed the basis of modern percutaneous coronary intervention . His primary interests are in performance of complex coronary intervention and the treatment of drug-refractory obstructive hypertrophic cardiomyopathy with the alcohol septal ablation procedure .


Send Email for John Douglas

Jai J. Khatri, MD

Section of Interventional Cardiology & Vascular Medicine
Cleveland Clinic
Cleveland Clinic

Dr. Jai Khatri is an interventional cardiologist at Cleveland Clinic Heart and Vascular Institute. His main area of clinical interest is in the treatment of coronary chronic total occlusions.


Send Email for Jai Khatri

James P. Stewart, MD, FSCAI

Emory University
Emory University

Dr. Stewart is a native Atlantan now an assistant professor at Emory and practicing interventional cardiology at Emory St. Joseph’s Hospital. He did all of his cardiology training at Emory including a dedicated year of advanced fellowship in structural heart disease which includes TAVRs and other advanced interventional cardiology procedures.


Send Email for James Stewart

Manesh R. Patel, MD, FSCAI

Director Interventional Cardiology and Catheterization Labs
Duke University Medical Center

Dr. Patel is cardiology section leader in Interventional Cardiology and Director of Cardiac Cath Labs for the Duke University Health System. His interests included peripheral and percutaneous intervention, and he is involved in several trials involving patients with vascular disease. He is also a member of the American College of Cardiology Task Force for Appropriate use of Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.


Send Email for Manesh Patel

Henry A. Liberman, MD, FSCAI

Emory Healthcare
Emory University

Dr. Liberman is Professor of Medicine (Cardiology) at Emory University School of Medicine and Director of the Cardiac Cath Lab and Interventional cardiology at Emory University Midtown. His main research interest are Acute Myocardial Infarction and Complex Coronary Intervention.


Send Email for Henry Liberman

Gautam Kumar, MD, FSCAI

Associate Professor
Emory University; Atlanta VA Medical Center
Emory University

Dr Gautam Kumar is an Associate Professor in the Cardiology Division at Emory University in Atlanta, GA. Based predominantly at the Atlanta VA Medical Center, he also participates actively in STEMI call and coverage at Emory University Hospital Midtown and Grady Memorial Hospital. Dr Kumar has significant interest in structural heart disease and has been involved with developing this at the Atlanta VA Medical Center. He brings unique perspective to this field as in addition to interventional cardiology, he is also a the Director of the Echocardiography laboratory at the Atlanta VA Medical Center. He is actively involved in clinical trials and device development. He is actively involved in high-risk PCI cases including CTOs, hemodynamic support and catheter-directed thrombolytics for PE.


Send Email for Gautam Kumar

Vasilis C. Babaliaros, MD


Dr Vasilis Babaliaros is Co-Director of the Emory Structural Heart and Valve Center. His expertise includes adult structural and congenital heart disease interventions. Dr Babaliaros has been on the Emory faculty for 10 years.


Send Email for Vasilis Babaliaros

Kendra J. Grubb, MD, MHA

Surgical Director, Structural Heart & Valve Center
Emory University
Emory University

Dr. Kendra Grubb is an Assistnat Professor of Surgery in the Division of Cardiothoracic Surgery at Emory University. She serves at the Surgical Director of the Structural Heart and Valve Center.


Send Email for Kendra Grubb

Dimitri Karmpaliotis, MD, PhD, FSCAI

Director of CTO and Complex and High Risk Angioplasty Program, Assistant Professor of Medicine
NYPH/Columbia University
Columbia University Medical Center

PhD in Vascular Biology. Residency at Brown University RI, Cardiology Fellowship at BIDMC/Harvard Medical School, Interventional Cardiology Fellowship at Emory University.
Currently Assistant Professor of Medicine at Columbia University Medical Center and Director of CTO, Complex and High Risk Angioplasty Program at the Center of Interventional Vascular Therapy, NYPH/Columbia University Medical Center, NY


Send Email for Dimitri Karmpaliotis


Live Case Demonstration #4

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Live Case Demonstration #4